Country, Other	Total Cases	New Cases	Total Deaths
World	51,233,658	+482,184	1,268,911
USA	10,422,026	+125,759	244,449
India	8,591,075	+37,211	127,104
Brazil	5,675,766	+11,651	162,638
France	1,807,479	+20,155	40,987
Russia	1,796,132	+21,798	30,793
Spain	1,426,602	+18,340	39,345
Argentina	1,250,499	+8,317	33,907
UK	1,213,363	+21,350	49,238
Colombia	1,149,063	+5,176	32,974
Mexico	967,825	+5,887	95,027
Italy	960,373	+25,271	41,750
Peru	923,527	+1,194	34,943
South Africa	738,525	+1,247	19,845
Iran	692,949	+10,463	38,749
Germany	688,972	+16,465	11,657
Poland	568,138	+21,713	8,045
Chile	522,879	+1,321	14,588
Iraq	501,733	+3,184	11,380
Belgium	500,789	+6,621	13,055
Ukraine	469,018	+8,687	8,565
Indonesia	440,569	+2,853	14,689
Bangladesh	421,921	+1,683	6,092
Czechia	417,181	+2,353	5,028
Netherlands	414,745	+4,680	8,043
Philippines	398,449	+2,058	7,647
Turkey	396,831	+2,576	10,972
Saudi Arabia	350,984	+392	5,559
Pakistan	344,839	+1,650	6,977
Israel	319,888	+647	2,678
Romania	306,991	+3,240	8,009
Canada	268,735	+4,622	10,564
Morocco	259,951	+3,170	4,356
Nepal	197,024	+2,571	1,126
Portugal	183,420	+4,096	2,959
Ecuador	175,269	+362	12,839
Austria	158,746	+5,593	1,454
UAE	143,289	+1,146	515
Bolivia	142,475	+48	8,795
Panama	140,331	+804	2,808
Qatar	134,433	+230	232
Kuwait	132,478	+735	816
Dominican	130,603	+421	2,267
Oman	118,503	+363	1,310
Costa Rica	117,587	+488	1,491
Kazakhstan	116,772	+610	1,857
Jordan	114,986	+5,665	1,295
Hungary	114,778	+5,162	2,493
Guatemala	111,360	+98	3,823
Egypt	109,422	+221	6,380
Japan	108,084	+998	1,818
Armenia	107,466	+1,042	1,580
Belarus	107,262	+983	1,011
Honduras	100,508	+467	2,751
Ethiopia	99,982	+307	1,530
Lebanon	95,355	+1,119	732
Venezuela	95,149	+266	830
China	86,245	+33	4,634
Bahrain	83,632	+176	329
Moldova	82,677	+331	1,912
Bulgaria	78,976	+3,816	1,771
Slovakia	76,072	+577	366
Tunisia	71,569	+450	1,920
Libya	69,040	+923	944
Uzbekistan	68,879	+149	586
Croatia	68,776	+1,529	832
Paraguay	67,948	+359	1,502
Azerbaijan	66,046	+635	852
Ireland	65,659	+265	1,948
Nigeria	64,184	+94	1,158
Serbia	64,065	+1,318	901
Kyrgyzstan	63,390	+571	1,182
Kenya	63,244	+756	1,130
Algeria	62,693	+642	2,062
Myanmar	61,975	+598	1,437
Georgia	60,680	+2,927	499
Palestine	58,838	+680	521
Greece	58,187	+1,489	825
Singapore	58,064	+8	28
Denmark	55,892	+771	747
Slovenia	45,625	+464	578
Malaysia	41,181	+972	294
North Macedonia	40,275	+515	1,156
Australia	27,668	+10	907
S. Korea	27,553	+126	480
Lithuania	25,755	+1,056	210
Norway	25,325	+593	285
Albania	24,731	+525	571
Montenegro	23,608	+803	342
Luxembourg	23,227	+176	193
Ivory Coast	20,835	+3	126
Finland	17,887	+90	363
Zambia	16,971	+17	349
Senegal	15,711	+3	326
Uganda	14,574	+171	133
Sudan	14,155	+65	1,116
Mozambique	13,823	+55	99
Namibia	13,240	+29	134
Angola	12,680	+247	308
Maldives	12,009	+23	40
DRC	11,608	+17	316
Tajikistan	11,376	+40	83
Cyprus	6,098	+111	28
Suriname	5,241	+2	113
Aruba	4,606	+6	41
Thailand	3,840	+3	60
Vietnam	1,215	+2	35

 

Retrieved from:  https://www.worldometers.info/coronavirus/

 

 

 

Brazil’s Health Surveillance Agency suspends Phase 3 trials of China's CoronaVac vaccine

From CNN’s Tatiana Arias in Atlanta

 

Vials of Sinovac Biotech Ltd.'s CoronaVac SARS-CoV-2 vaccine are displayed at a media event in Beijing, China, on September 24. Nicolas Bock/Bloomberg/Getty Images

Brazil’s National Health Surveillance Agency (Anvisa) has suspended phase 3 clinical trials of a Chinese-developed Covid-19 vaccine following an "adverse" incident involving a volunteer recipient, according to sources cited by CNN’s affiliate, CNN Brasil.

CoronaVac, developed by Chinese pharmaceutical company Sinovac Biotech, began phase 3 trials of CoronaVac in collaboration with the Brazilian Butantan Institute in Sao Paulo in late July.

According to CNN Brasil, the studies were suspended due to the "occurrence of serious adverse event in one of the volunteers in Brazil." No further details were provided owing to privacy regulations.

The pause in testing marks a potential setback for one of China's leading vaccine candidates and comes as US drugmaker Pfizer said Monday that early data from its own coronavirus vaccine showed more than 90% effectiveness.

In a note obtained by CNN Brasil, Anvisa mentions a case on October 29 for which the agency “determined the interruption of the clinical study,” adding that it “decided to interrupt the study to evaluate the data observed so far and judge on the risk/benefit of continuing the study.”

“With the study interrupted, no new volunteers can be vaccinated,” reads the Anvisa note published by CNN Brasil late Monday.

The CoronaVac trial vaccine uses inactivated virus cells to stimulate an immune response in patients. Testing began in late July, with 9,000 volunteers in five Brazilian states plus the capital. 

The Butantan Institute said it will hold a press conference Tuesday morning local time, according to CNN Brasil.

 

Retrieved from: https://edition.cnn.com/world/live-news/coronavirus-pandemic-11-10-20-intl/index.html

 

 

 

Hungary and Portugal plan curfews and new restrictions as cases surge

 

A soldier disinfecting the staircase in an elementary school in Szolnok, Hungary, last month

Hungary and Portugal are the latest European countries to adopt new measures like curfews and limits on gatherings to curb rapid rises in new coronavirus cases.

Prime Minister Viktor Orban of Hungary said there would be a general curfew from 8 p.m. to 5 a.m., and that all public events would be banned, with family and private gatherings capped at 10 people. Restaurants will only offer delivery services and hotels will be limited to catering to business travelers.

High schools and higher education institutions will be moving to online classes, and dormitories will be closed, although nurseries, kindergartens and primary schools will remain open. Sporting events will be held behind closed doors and gyms, indoor swimming pools, museums, theaters and zoos will be closed.

The government will also extend some benefits, including payroll tax cuts and salary contributions, to the tourism and hospitality sector.

The new rules will need to be approved by Parliament, which is controlled by Mr. Orban’s party, and would be in place for 30 days.

Nearly 2,500 people have died after contracting the virus in Hungary since the start of the year, according to government figures, with three-quarters of the deaths occurring after Sept. 1. More than 114,000 people have tested positive for the virus in Hungary.

Portugal returned on Monday to a state of emergency that gives its government enhanced powers to impose lockdown measures to stop a second wave of infections.

But the government has so far opted for relatively lenient restrictions compared with those introduced recently in some other European countries. As of Monday, about 7.1 million of the 10 million residents of Portugal must respect a nighttime curfew that runs from 11 p.m. to 5 a.m., as well as a stricter one during the coming two weekends, from 1 p.m. to 5 a.m.

The government said it would review the situation after Nov. 23 before deciding whether to extend the state of emergency.

On Friday, the country registered 5,550 new coronavirus cases, the highest daily figure since the pandemic started. The number of patients in Portugal’s intensive care units has also climbed this month to over 300, which is more than at the peak in April.

In Andalusia, the southern region of Spain that borders Portugal and is home to about 8.4 million people, the regional authorities have ordered residents to remain within their municipalities.

Bars and restaurants must close at 6 p.m., except in the province of Granada, where establishments must remain fully shuttered because of the high infection rate. Andalusia now has 457 Covid-19 patients in intensive care units, which is also a record.

 

 

France’s latest lockdown is taking a smaller toll on the economy

 

Commuters wait for a train on the Paris underground last week. France’s latest lockdown is taking less of a toll on the economy than the shutdown imposed earlier this year, the central bank said

A new partial lockdown to contain the spread of the coronavirus in France is having a smaller impact on the national economy than a total lockdown earlier this year, the French central bank said Monday. But business leaders still expect a sharp decline in activity across the board in November, as order books at construction companies shrink, the bank added.

France’s second lockdown, which began Oct. 17 and is now expected to stretch beyond Dec. 1, was aimed at minimizing damage to the economy just as a recovery was starting to take hold during a summer rebound. Unlike the earlier lockdown, France is allowing public services and schools to stay open, and activity at construction and factory sites to continue.

The Banque de France said it expected the economy was likely to show a shrinkage of about 12 percent in November from a year ago. That compares with a wrenching 31 percent year-over-year contraction in April, when economic activity ground to a halt.

Whether that improvement lasts remains to be seen. Fears of coronavirus outbreaks have worsened the outlook for French business activity, and are likely to lead to a wave of layoffs, economists say.

French companies have said they expect earnings to decline in 2021, and they don’t expect to substantially increase spending on capital investment.

Working from home, and the use of socially distanced workplaces has so far helped maintain corporate activity. The opening of schools is easing child care burdens for employees with children.

Activity in agro-foods, pharmaceuticals and other industrial sectors enjoyed a bounce after an earlier national quarantine, and are now back to pre-pandemic levels, the central bank added.

At the same time, a quarter of the economy remains hard hit by social-distancing measures, including hotels, restaurants, tourism and catering, the central bank said.

 

Retrieved from: https://www.nytimes.com/live/2020/11/09/world/covid-19-coronavirus-live-updates?name=styln-coronavirus®ion=TOP_BANNER&block=storyline_menu_recirc&action=click&pgtype=LegacyCollection&impression_id=6163d3f1-2320-11eb-98d1-05753d8b6195&variant=undefined

 

 

 

Belgium confident second wave of hospital admissions has peaked

 

 

People wearing masks walk near the European Commission headquarters in Brussels, Belgium, on 8 November 2020 Photograph: Xinhua/REX/Shutterstock

Some more positive news to share – this time from Belgium. The country’s health authorities say they are confident that a second wave of Covid-19 hospital admissions has peaked in Belgium and will now begin to decline.

Speaking at a news conference reported by the Associated Press, virologist Yves Van Laethem said about 400 people were hospitalised due to coronavirus complications on Sunday, compared with 879 on 3 November.

“Subject to an unpleasant surprise,” the peak in hospital admissions was reached that day, Van Laethem said. Some 6,948 Covid-19 patients are currently being treated in Belgian hospitals – about 500 fewer than on 3 November.

Belgium has returned to partial lockdown measures including the closure of nonessential shops, bars and restaurants, as well as the extension of the autumn school vacation. Van Laethem said the measures seem to have had an impact as the number of patients in intensive care was tending to stabilise.

 

Retrieved from: https://www.theguardian.com/world/live/2020/nov/09/coronavirus-live-news-us-nears-10m-cases-as-global-infections-pass-50m?page=with:block-5fa931808f083df739ba7b28#block-5fa931808f083df739ba7b28

 

 

 

Brazil halts trials of Chinese Covid-19 vaccine

 

The Governor of the state of Sao Paulo, Joao Doria (L), and the director of the Butantan Institute, Dimas Covas (R), present a version of the Chinese Coronavac vaccine during a press conference in Sao Paulo, Brazil, 9 November 2020. Photograph: Sebastião Moreira/EPA

Brazil’s health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an “adverse incident” involving a volunteer recipient, a blow for one of the most advanced vaccine candidates, AFP reports.

The setback for CoronaVac, developed by Chinese pharmaceutical firm Sinovac Biotech, came on the same day US pharmaceutical giant Pfizer said its own vaccine candidate had shown 90 percent effectiveness, sending global markets soaring and raising hopes of an end to the pandemic.

The Brazilian regulator, Anvisa, said in a statement it had “ruled to interrupt the clinical study of the CoronaVac vaccine after a serious adverse incident” on 29 October.

It said it could not give details on what happened because of privacy regulations, but that such incidents included death, potentially fatal side effects, serious disability, hospitalisation, birth defects and other “clinically significant events.”

However, the public health centre coordinating the trials of the vaccine in Brazil, the Butantan Institute, said it was “surprised” by the decision.

The institute “is investigating in detail what happened,” and “is at the Brazilian regulatory agency’s disposal to provide any clarification necessary on any adverse incident the clinical trials may have presented,” it said.

It said it would hold a press conference on Tuesday at 11:00 am (1400 GMT).

CoronaVac has been caught up in a messy political battle in Brazil, where its most visible backer has been Sao Paulo Governor Joao Doria, a top opponent of far-right President Jair Bolsonaro.

The Sao Paulo state government said in a statement it “regrets that it learned of the decision from the press, instead of directly from Anvisa,” and was waiting along with the Butantan Institute for more information on “the real reasons for the suspension.”

 

 

Summary

 

Here are the key developments from the last few hours:

· China inflation dips to 11-year low as pork stocks rise. Falling food prices dragged China’s consumer inflation to an 11-year low last month, spurred by improving supplies of pork, official data showed Tuesday.

· Blocking Taiwan at WHO will increase hostility to China, premier says. China’s efforts to block Taiwan’s participation at the World Health Organisation during the coronavirus pandemic will only increase the world’s hostility towards the country, the island’s premier said on Tuesday.

· Australia records third day with no local cases. Australia has gone three days without any locally acquired cases of Covid-19. All cases have been detected in quarantined locals who have recently returned from overseas.Now the country is considering opening its borders to Asian countries, including parts of China, Prime Minister Scott Morrison said on Tuesday, as Canberra seeks to revive an economy ravaged by Covid-19.

· Monday saw record Covid patients in US hospitals. There were almost 59,000 Covid-19 patients in hospitals across the United States on Monday, the country’s highest number ever of in-patients being treated for the disease. The number of people with the virus being hospitalized has surged around 73% over the past 30 days to at least 58,982 - a record level that surpasses the previous high of 58,370 on July 22.

· US FDA authorises emergency use of Eli Lilly’s experimental treatment for Covid. The US Food and Drug Administration on Monday authorised emergency use of Eli Lilly and Co’s experimental Covid-19 antibody treatment for non-hospitalised patients older than 65 or who have certain chronic medical conditions. The FDA said its emergency use authorisation (EUA) was based on clinical trials showing that the treatment, bamlanivimab, reduced the need for hospitalisation or emergency room visits in Covid-19 patients at high risk of disease progression.

· Brazil halts trials of Chinese Covid-19 vaccine. Brazil’s health regulator said Monday it had suspended clinical trials of a Chinese-developed Covid-19 vaccine after an “adverse incident” involving a volunteer recipient, a blow for one of the most advanced vaccine candidates, AFP reports.The setback for CoronaVac, developed by Chinese pharmaceutical firm Sinovac Biotech, came on the same day US pharmaceutical giant Pfizer said its own vaccine candidate had shown 90 percent effectiveness, sending global markets soaring and raising hopes of an end to the pandemic.

· World may be tired, but virus ‘not tired of us’: WHO chief. The World Health Organization’s chief called Monday on everyone to keep fighting Covid-19, warning that while we may be sick of battling the pandemic, the virus is “not tired of us”, AFP reports.Speaking to WHO’s main annual assembly, which resumed Monday after being cut short in May, Tedros Adhanom Ghebreyesus also hailed the election of Joe Biden as the next US president, voicing hope it could signal tighter global cooperation to end the pandemic.

· Italy will ramp up coronavirus restrictions in Tuscany and four other regions from Wednesday to rein in the second wave of the pandemic, a health ministry source said on Monday. Last week, the government imposed nationwide curbs including a nightly curfew, and divided the country into three zones based on the intensity of their Covid-19 outbreaks, calibrating additional limitations accordingly.

· The US president-elect Joe Biden led the tone for much of the reaction from world leaders. He said it could be “many months” before the vaccine is widely available – providing it passes several more hurdles in the approval and distribution process – and warned Americans: “We’re still facing a very dark winter.”

· Sir John Bell, one of the UK’s most eminent vaccines experts, said he believed “with some confidence” that life should return to normal by spring next year following the Pfizer/BioNTech announcement. Bell went further than many of peers in the scientific community but his prediction carries significant weight given his role on the UK’s vaccines taskforce.

· A senior World Health Organisation official said a Covid-19 vaccine may be rolled out by March 2021 to the most vulnerable. Bruce Aylward told the WHO’s annual ministerial assembly that interim results from Pfizer’s late-stage vaccine trial were “very positive”.

 

Retrieved from: https://www.theguardian.com/world/live/2020/nov/10/coronavirus-live-news-who-warns-covid-not-tired-of-us-as-top-uk-scientist-says-vaccine-feels-like-watershed-moment?page=with:block-5faa2e238f086b290cc535d6#block-5faa2e238f086b290cc535d6